Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Capillary microscopy is a potentially useful method for detecting bleomycin vascular toxicity.

J Bellmunt1, M Navarro, S Morales

  • 1Department of Oncology, Hospital Valle Hebron, Barcelona, Spain.

Cancer
|January 15, 1990
PubMed
Summary

Capillary microscopy can detect bleomycin-induced vascular damage in patients with cancer, even before symptoms appear. This noninvasive technique identifies specific vascular patterns linked to bleomycin treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Avelumab first-line maintenance for advanced urothelial carcinoma: long-term outcomes from the JAVELIN Bladder 100 trial in patients with high body mass index or diabetes mellitus.

ESMO open·2026
Same author

Avelumab first-line maintenance for advanced urothelial carcinoma: long-term outcomes from the JAVELIN Bladder 100 trial in older patients.

ESMO open·2025
Same author

Sacituzumab govitecan in advanced urothelial carcinoma: TROPiCS-04, a phase III randomized trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Atezolizumab monotherapy for metastatic urothelial carcinoma: final analysis from the phase II IMvigor210 trial.

ESMO open·2024
Same author

Determining fitness for enfortumab vedotin and pembrolizumab in metastatic bladder cancer: the time to move beyond isolated comorbidity assessments.

ESMO open·2024
Same author

The clinical use of enfortumab vedotin and pembrolizumab in patients with advanced urothelial carcinoma: using clinical judgement over treatment criteria.

ESMO open·2024

Area of Science:

  • Oncology
  • Vascular Biology
  • Diagnostic Imaging

Background:

  • Bleomycin (BLEO) is a chemotherapy agent known to cause vascular-associated diseases.
  • Early detection of subclinical vascular toxicity is crucial for managing patients undergoing chemotherapy.

Purpose of the Study:

  • To evaluate the utility of capillary microscopy in detecting subclinical vascular damage induced by bleomycin in cancer patients.
  • To correlate capillary microscopy findings with bleomycin treatment history and dosage.

Main Methods:

  • Capillary microscopy was performed on 40 patients with neoplasia.
  • Patients were categorized based on prior bleomycin exposure and dosage.
  • Vascular activity patterns, defined by capillary tortuosity and ramifications, were assessed.

Related Experiment Videos

Main Results:

  • Fourteen patients exhibited "vascular activity patterns" (P = 0.035), with 10 having received bleomycin.
  • Patients treated with bleomycin and normal capillary microscopy results generally received lower cumulative doses (<100 U).
  • No patients displayed clinical signs of vascular toxicity.

Conclusions:

  • Capillary microscopy is a valuable noninvasive tool for identifying bleomycin-induced vascular damage in asymptomatic patients.
  • The presence of specific vascular patterns may indicate early-stage bleomycin cardiotoxicity.
  • Further research is warranted to establish the predictive value of capillary microscopy for bleomycin-related vascular complications.